Re-hospitalization
Conditions
Brief summary
The study is a randomized controlled clinical trial. A total 1400 hospitalized patients will be randomized in two groups: 1. group receiving a pharmacist-led standardized medication review (experimental group); and 2. group not receiving the medication review (control group). The patients will be followed up at 30 days after initial hospitalization. Outcome measures include the number of readmissions; patient satisfaction, quality of medical admission prescription and number of consultation after initial hospitalization. Discussion: A randomized controlled trial will provide the highest level of evidence on the impact of pharmacist-led standardized medication review on early hospital readmission for extreme age population.
Detailed description
The impact of Medication Reconciliation on the early hospital readmission in the elderly is not clearly demonstrated. Moreover, the impact of medication reconciliation in the pediatric population is poorly studied. In such context, it is important to demonstrate the effectiveness of the medication reconciliation as part of a standardized medication review process, in pediatric and in the elderly, on all cause readmissions in a large randomized control clinical trial. The standardized medication review process includes medication reconciliation, treatment review and medication liaison service. The main objective of this study is to assess the impact of the standardized medication review on the rate of readmissions and/or death at 30 days following initial hospitalization discharge. Methods/design: The study is a randomized controlled clinical trial. A total 1400 hospitalized patients will be randomized in two groups: 1. group receiving a pharmacist-led standardized medication review (experimental group); and 2. group not receiving the medication review (control group). The patients will be followed up at 30 days after initial hospitalization. Outcome measures include the number of readmissions; patient satisfaction, quality of medical admission prescription and number of consultation after initial hospitalization. Discussion: A randomized controlled trial will provide the highest level of evidence on the impact of pharmacist-led standardized medication review.
Interventions
OTHERpharmacist-led standardized medication review
the goal of this study is to assess the impact of the standardized medication review on the rate of readmissions and/or death at 30 days following initial hospitalization discharge.
Sponsors
Assistance Publique Hopitaux De Marseille
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Subjects aged under 18 or over 65 years * Subject hospitalized in the multidisciplinary pediatric service or internal medicine ward, after emergency department visit at Timone hospital (Marseille, France) regardless of the reason for admission * Subject with or without any comorbidity * Living in France * With national publicly-founded health insurance Inclusion criteria for parents of minor child: * Major subject and/or holder of parental authority of a hospitalized child, who fulfills the eligibility criteria mentioned above, in the multidisciplinary pediatric ward; * Whatever the reason for hospitalization of the patient; Inclusion criteria for the caregivers of patients older than 65 years: * Major subject, designated by the patient or designating himself as the person most involved in the daily life of the patient; * Whatever the reason for hospitalization of the patient; * Whatever relationship or proximity to the study patient (family member, friend, neighbor);
Exclusion criteria
* Patients whose care requires regular re-hospitalization / programmed less than 30 days after discharge of initial hospitalization * Vulnerable persons according to French law (pregnant women, adults under guardianship, persons deprived of liberty)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of readmission | 30 days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Satisfaction with Medicines Questionnaire (SatMed-Q®) | 30 days | Patient satisfaction with regards to its drug treatment will be measured using the standardized questionnaire Satisfaction with Medicines Questionnaire (SatMed-Q®) validated in French |
| Medication errors on medical admission prescription | 24 hours | Medical admission prescription will be assessed using the number of discrepancies and the number of medication errors, |
| Number of consultations post discharge | 30 days | The number of consultations scheduled or not within 30 days' post-hospitalization will be studied. Consultations are defined as interviews with the attending physician, a specialist physician, nurse, therapeutic educator, and psychologist. |
Countries
France
Outcome results
None listed